Skip to main content

CORRECTION article

Front. Neurosci., 22 August 2018
Sec. Neurogenomics

Corrigendum: Identification of the CFTR c.1666A>G Mutation in Hereditary Inclusion Body Myopathy Using Next-Generation Sequencing Analysis

\r\nYan LuYan Lu1Yu-Wei Da*Yu-Wei Da1*Yong-Biao Zhang*Yong-Biao Zhang2*Xin-Gang Li,Xin-Gang Li3,4Min WangMin Wang1Li DiLi Di1Mi PangMi Pang5Lin LeiLin Lei1
  • 1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
  • 2Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Beijing, China
  • 3Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China
  • 4School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia
  • 5Department of Neurology, Zhengzhou University People's Hospital, Zhengzhou, China

A Corrigendum on
Identification of the CFTR c.1666A>G Mutation in Hereditary Inclusion Body Myopathy Using Next-Generation Sequencing Analysis

by Lu, Y., Da, Y.-W., Zhang, Y.-B., Li, X.-G., Wang, M., Di, L., et al. (2018). Front. Neurosci. 12:329. doi: 10.3389/fnins.2018.00329

An error was found in the first and second sentence of the original article's abstract.

It had originally been published as:

Hereditary inclusion body myopathy (HIBM) is a rare autosomal recessive adult onset muscle disease which affects one to three individuals per million worldwide. This disease is autosomal dominant and occurs in adulthood.

The corrected sentences should read:

Hereditary Inclusion Body Myopathy (HIBM) is a rare autosomal dominant or recessive adult onset muscle disease which affects one to three individuals per million worldwide. This disease is autosomal dominant or recessive and occurs in adulthood.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: hereditary inclusion body myopathy, next-generation sequencing, CFTR, mutation, whole-exome sequencing

Citation: Lu Y, Da Y-W, Zhang Y-B, Li X-G, Wang M, Di L, Pang M and Lei L (2018) Corrigendum: Identification of the CFTR c.1666A>G Mutation in Hereditary Inclusion Body Myopathy Using Next-Generation Sequencing Analysis. Front. Neurosci. 12:570. doi: 10.3389/fnins.2018.00570

Received: 10 July 2018; Accepted: 27 July 2018;
Published: 22 August 2018.

Edited and reviewed by: Hua Lou, Case Western Reserve University, United States

Copyright © 2018 Lu, Da, Zhang, Li, Wang, Di, Pang and Lei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yu-Wei Da, yuwei_da@163.com
Yong-Biao Zhang, zhangyongbiao@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.